Assessment of lncRNA GAS5, lncRNA HEIH, lncRNA BISPR and its mRNA BST2 as serum innovative non-invasive biomarkers: Recent insights into Egyptian patients with hepatitis C virus type 4

doi:10.3748/wjg.v26.i2.168

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7681)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-5) series.

Item

Count

PDF

662

WORD

210

HTML

3754

Figures (1-5)

458

Tables (1-5)

457

Sum=5541

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

842

Download

1298

Sum=2140

Jan 14, 2020 (publication date) through Jan 12, 2025

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Jan 14, 2020; 26(2): 168-183
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.168

Full Size Figure Download Figure

Figure 4 Differential expression of serum lncRNAs and mRNA levels in hepatitis C virus relapsed, naïve and SOF + SIM treated hepatitis C virus patients. ^aP < 0.05, ^bP < 0.01, vs naïve group; ^dP < 0.01, vs SOF + SIM group.

Citation: El Samaloty NM, Shabayek MI, Ghait RS, El-Maraghy SA, Rizk SM, El-Sawalhi MM. Assessment of lncRNA GAS5, lncRNA HEIH, lncRNA BISPR and its mRNA BST2 as serum innovative non-invasive biomarkers: Recent insights into Egyptian patients with hepatitis C virus type 4. World J Gastroenterol 2020; 26(2): 168-183
URL: https://www.wjgnet.com/1007-9327/full/v26/i2/168.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i2.168